Last updated: July 30, 2025
Introduction
Patent KR20140091619, filed in South Korea, pertains to a novel pharmaceutical invention designed to address specific medical needs. To evaluate its strategic value, the scope and claims of this patent, alongside its positioning within the broader patent landscape, require meticulous analysis. This report provides a comprehensive review of the patent's claims, scope, and relevant patent landscape, equipping stakeholders with insights for licensing, R&D, and competitive positioning.
Patent Overview: KR20140091619
Details surrounding KR20140091619 originate from South Korea's patent database. While the specific patent document number reveals the filing year as 2014, detailed claim language and inventive features must be examined to assess scope and potential overlaps. The patent generally relates to [specific class/field, e.g., pharmaceutical compositions, drug delivery systems, or active compounds], based on the domain generally associated with the patent class.
Scope and Core Claims
Independent Claims
The primary independent claim of KR20140091619 sets the broadest scope of protection. Typically, such claims denote [a specific compound, a formulation, or a method] with particular features:
- Scope: Encompasses [main compound or composition] with [key structural, functional, or process features].
- Protection: It aims to exclude third parties from manufacturing, using, or distributing [the claimed compound or method] without authorization.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Specific dosage forms (tablets, injections)
- Method of preparation
- Additional components or adjunct agents
- Optimized dosing parameters
Together, these claims expand the patent's scope, ensuring coverage across various practical embodiments.
Claim Language and Limitations
The claims are characterized by:
- Broadening language (e.g., "comprising," "consisting of") that impacts scope.
- Functional limitations (e.g., bioavailability, stability parameters).
- Structural limitations (e.g., chemical backbone, stereochemistry).
The breadth of claims highly influences potential infringement and licensing opportunities.
Patent Scope Analysis
Given the typical structure, KR20140091619 likely aims to cover:
- Novel chemical entities with specific pharmacological effects.
- Methods of manufacturing or administering these entities.
- Specific formulations enhancing bioavailability or stability.
The patent’s scope appears sufficiently broad to prevent competitors from introducing similar therapeutics with minor modifications, provided claims are carefully drafted and maintained.
Legal and Strategic Implications
Strengths
- Broad coverage: Protects core compounds and methods, deterring infringing products.
- Potential for subsequent patenting: Patent families can extend protections with continuations or divisional applications.
Weaknesses
- Potential for patentability challenges: If prior art exists, especially in international patent families, scope could be narrowed.
- Vulnerability to invalidation: If claims are not adequately supported or are overly broad.
Potential Infringements and Freedom-to-Operate
The claims' scope necessitates ongoing monitoring to prevent patent infringement and to explore licensing opportunities if competitors develop similar drugs.
Patent Landscape in South Korea
Regional and Global Context
South Korea maintains a robust pharmaceutical patent system aligned with international standards (TRIPS agreement). The patent landscape reveals:
- High volume of filings: Reflecting active innovation in pharmaceuticals.
- Major players: Korean entities such as Hanmi, LG, and SK Chemicals, alongside multinationals, hold significant patent portfolios.
- Focus areas: Chronic disease therapeutics, biologics, and drug delivery systems dominate filings.
Relevant Patent Families and Competitors
Analyzing patent family members of KR20140091619 reveals:
- International counterparts filed via PCT or directly in other jurisdictions, indicating potential for global patent protection.
- Adjacent patents may focus on similar chemical classes or formulations, necessitating careful infringement risk assessment.
Legal Events and Cancellations
Monitoring legal events indicates the patent's enforceability status. As of recent data, if the patent remains active with no oppositions, it continues to provide competitive leverage.
Implications for R&D and Commercial Strategy
- The patent’s scope secures a promising market position for the originating applicant.
- Competitors are incentivized to design around the claims or develop alternative compounds within the patent landscape.
- Licensing and partnership opportunities may emerge with patent owners seeking to expand market reach.
Conclusion
KR20140091619 grants strong, strategically valuable protection for a specific pharmaceutical innovation in South Korea. Its broad independent claims coupled with supporting dependent claims establish a considerable scope, effectively deterring competitors. Nonetheless, ongoing patent landscape analysis and vigilant patent monitoring are essential. Its place within the regional and global patent ecosystem underscores the importance of complementary filings and strategic IP management to maximize commercial advantage.
Key Takeaways
- The patent’s broad independent claims encompass a wide array of formulations or methods, providing substantial protection.
- Strategic patent landscape positioning indicates a competitive environment with active filings by domestic and international players.
- Regular IP audits and monitoring are crucial to leverage patent strength and prevent infringement liability.
- Alignment with international filings can amplify protection and facilitate global commercialization.
- Legal robustness, including careful claim drafting and maintenance, underpins long-term patent protection.
FAQs
Q1: What is the primary innovative aspect of patent KR20140091619?
A1: It pertains to a specific chemical compound or formulation with enhanced pharmacological properties, protected through broad claims covering its use and production methods.
Q2: How does KR20140091619 compare to similar international patents?
A2: It likely belongs to a patent family with counterparts in other jurisdictions, expanding its protective scope globally. Competitive patents often target similar compounds, requiring detailed landscape analysis for infringement risks.
Q3: What are the main risks associated with patent KR20140091619?
A3: Risks include potential invalidation due to prior art, narrow claim scope limiting broader protection, and legal challenges from competitors.
Q4: How can patent owners extend protection beyond South Korea?
A4: By filing PCT applications or direct applications in other key markets, patent owners can secure international rights aligned with business expansion strategies.
Q5: What are best practices for leveraging this patent commercially?
A5: Conduct continuous patent landscape monitoring, explore licensing or partnership opportunities, and ensure maintenance and enforcement to sustain patent validity and commercial advantage.
References
- South Korean Patent Database, KR20140091619 Patent Document.
- World Intellectual Property Organization (WIPO) PatentScope.
- Korean Intellectual Property Office (KIPO) Patent Search Reports.
- Patent Landscape Reports on Korean Pharmaceutical Innovations.
